NM_007049.5:c.400G>A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_007049.5(BTN2A1):c.400G>A(p.Asp134Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,613,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007049.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTN2A1 | NM_007049.5 | c.400G>A | p.Asp134Asn | missense_variant | Exon 3 of 8 | ENST00000312541.10 | NP_008980.1 | |
BTN2A1 | NM_001197233.3 | c.217G>A | p.Asp73Asn | missense_variant | Exon 2 of 7 | NP_001184162.1 | ||
BTN2A1 | NM_078476.4 | c.400G>A | p.Asp134Asn | missense_variant | Exon 3 of 8 | NP_510961.1 | ||
BTN2A1 | NM_001197234.3 | c.400G>A | p.Asp134Asn | missense_variant | Exon 3 of 8 | NP_001184163.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251124Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135728
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461768Hom.: 0 Cov.: 32 AF XY: 0.0000619 AC XY: 45AN XY: 727180
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.400G>A (p.D134N) alteration is located in exon 3 (coding exon 2) of the BTN2A1 gene. This alteration results from a G to A substitution at nucleotide position 400, causing the aspartic acid (D) at amino acid position 134 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at